The Coxast® Difference
Our Science
Coxast® is clinically tested.
Usage of Coxast® in clinical practice has been evaluated in Ileal pouchitis.
Usage of Coxast® in clinical practice has been evaluated for IBS.
Coxast® has been the subject of more than 40 scientific publications in the last five years alone.
Usage of Coxast® in clinical practice has been evaluated for Ulcerative Colitis.
More than 10 human clinical studies on Coxast® have been published in the last 5 years.


Email Patient a Discount Code
Advanced Probiotics
Daily Probiotics: Appropriate for a range of patient types.
Optimal gut health starts with an advanced, multi-strain probiotic
Optimal gut health starts with an advanced, multi-strain probiotic
Multi-strain probiotics are beneficial for certain patients who have underlying dysbiosis, an imbalance in the “good” and “bad” gut microflora, particularly those with IBS, UC and pouchitis.
Multi-strain probiotics have been shown to also be potentially beneficial for patients who have:
Multi-strain probiotics have been shown to also be potentially beneficial for patients who have:
- Recently been treated with a course of antibiotics
- Have taken certain prescription medications
- Undergone medical interventions such as colonoscopy
- Changes in gut flora due to dietary changes or aging
- Type 2 diabetes
An advanced, powerful probiotic can address dysbiosis in a variety of patients.

Diversity, viability, and potency are essential features of an advanced, effective probiotic.
Diversity
Diversity
Combining multiple bacterial strains provides a range of benefits that cannot be achieved with single-strain probiotics.
Viability
Viability
Probiotics must survive the acidic stomach environment in order to colonize the gut with health-promoting bacteria, restore healthy microbial balance, and reduce overgrowth of pathogens.
Potency
Potency
Probiotics that contain an optimal concentration of colony-forming units (CFUs) can maximize delivery of commensal live bacteria.